France will begin reimbursing weight-loss drugs for severely obese patients from mid-June, marking a first for an EU country. This move aims to address rising obesity rates across Europe.

France ⁠will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a first for a European Union country, Health Minister Stephanie Rist said on Thursday. Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro medications have led a boom ‌in anti-obesity treatment, attracting interest from governments keen to address rising overweight levels worldwide. Rist estimated the annual cost to the state at around €100 million (US$116 million) at full roll-out. Patients in...